Treatment of intracerebral hemorrhage with tranexamic acid after thrombolysis with tissue plasminogen activator

Neurocritical Care

Volumn 17, Issue 1, 2012, Pages 107-111

  French, K F ^a   White, Jacob ^b   Hoesch, R E ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH HOSPITAL   (United States)

Author keywords

All cerebrovascular disease stroke; Critical care; Infarction; Intracerebral hemorrhage; Thrombolysis

Indexed keywords

PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID;

ADULT; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG MECHANISM; FIBRINOLYTIC THERAPY; HUMAN; JEHOVAH'S WITNESS; LOADING DRUG DOSE; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE;

ANTIFIBRINOLYTIC AGENTS; CEREBRAL HEMORRHAGE; DRUG INTERACTIONS; FATAL OUTCOME; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID;

EID: 84864284735     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9681-5     Document Type: Article

References (14)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group 1995 Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1581 1587 10.1056/NEJM199512143332401
2. MG Lansberg E Bluhmki VN Thijs 2009 Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis Stroke 40 7 2438 2441 19478213 10.1161/STROKEAHA.109.552547 1:CAS:528:DC%2BD1MXnsFyjurc%3D
3. O Adeoye R Hornung P Khatri D Kleindorfer 2011 Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years Stroke 42 7 1952 1955 21636813 10.1161/STROKEAHA.110.612358 1:CAS:528:DC%2BC3MXotFSrtbc%3D
4. LB Morgenstern JC Hemphill 3rd C Anderson 2010 Guidelines for the management of spontaneous intracerebral hemorrhage. A guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 41 9 2108 2129 20651276 10.1161/STR.0b013e3181ec611b
5. I Roberts H Shakur K Ker T Coats CRASH-2 Trial collaborators 2011 Antifibrinolytic drugs for acute traumatic injury Cochrane Database Syst Rev 19 1 CD004896
6. AP Cap DG Baer JA Orman, et al. 2011 Tranexamic acid for trauma patients: a critical review of the literature J Trauma 71 1 Suppl S9 S14 21795884 10.1097/TA.0b013e31822114af 1:CAS:528:DC%2BC3MXos1GlsLw%3D
7. CRASH-2 trial collaborators, et al. 2010 Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial Lancet 376 9734 23 32 10.1016/S0140-6736(10)60835-5
8. K Nardi G Pelone M Bartolo, et al. 2011 Ischaemic stroke following tranexamic acid in young patients carrying heterozygosity of MTHFR C677T Ann Clin Biochem 48 575 578 21903703 10.1258/acb.2011.011101 1:CAS:528: DC%2BC3MXhs1KktrrJ
9. Roos YB, Rinkel GJ, VermeulenM, Algra A, van Gijn J. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2003; (2): CD001245.
10. CRASH-2 Collaborators, Intracranial Bleeding Study 2011 Effect of tranexamic acid in traumatic brain injury: a nested randomized, placebo controlled trial (CRASH-2 Intracranial Bleeding Study) BMJ 343 d3795 10.1136/bmj.d3795
11. JN Goldstein M Merrero S Masrur, et al. 2010 Management of thrombolysis-associated symptomatic intracerebral hemorrhage Arch Neurol 67 8 965 969 20697046 10.1001/archneurol.2010.175
12. Dirkman D, Gorlinger K, Gisbertz C, DusseF, Peters J. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood. Anesth Analg. 2011 (epub ahead of print).
13. A Koster U Schirmer 2011 Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era Curr Opin Anaesthesiol 24 1 92 97 20881484 10.1097/ACO.0b013e32833ff3eb
14. S Imbesi E Nettis PL Minciullo E Di Leo A Saija S Gangemi 2010 Hypersensitivity to tranexamic acid: a wide spectrum of adverse reaction Pharm World Sci 32 416 419 20632108 10.1007/s11096-010-9415-8 1:CAS:528: DC%2BC3cXpvV2gsrY%3D